mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.1 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.1 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |